ArticleSaudi journal of biological sciences2022

CB-RAF600E-1 exerts efficacy in vemurafenib-resistant and non-resistant-melanoma cells via dual inhibition of RAS/RAF/MEK/ERK and PI3K/Akt signaling pathways.

Mesfer Al Shahrani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.